|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 21.65 TWD | -1.37% |
|
-1.37% | +29.25% |
| Capitalization | 17.12B 544M 460M 420M 401M 743M 49.31B 769M 4.89B 1.94B 23.79B 2.04B 2B 83.93B | P/E ratio 2025 * |
67.7x | P/E ratio 2026 * | 54.1x |
|---|---|---|---|---|---|
| Enterprise value | 17.12B 544M 460M 420M 401M 743M 49.31B 769M 4.89B 1.94B 23.79B 2.04B 2B 83.93B | EV / Sales 2025 * |
5.46x | EV / Sales 2026 * | 5.2x |
| Free-Float |
27.65% | Yield 2025 * |
-
| Yield 2026 * | - |
| 1 day | -1.37% | ||
| 1 week | -1.37% | ||
| Current month | -12.17% | ||
| 1 month | -17.52% | ||
| 3 months | +25.51% | ||
| 6 months | +24.07% | ||
| Current year | +29.25% |
| 1 month | 21.1 |  | 29.1 |
| Current year | 16.7 | | 29.1 |
| 1 year | 16.25 | | 29.1 |
| 3 years | 16.25 | | 35.8 |
| 5 years | 16.25 | | 35.8 |
| 10 years | 16.25 | | 52.14 |
| Manager | Title | Age | Since |
|---|---|---|---|
Susan Lu
CEO | Chief Executive Officer | - | - |
Chih Ching Hsu
DFI | Director of Finance/CFO | - | 19/08/2018 |
Cynthia Hung
CTO | Chief Tech/Sci/R&D Officer | - | 17/05/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
Chih Hsien Lo
CHM | Chairman | 69 | 13/08/2017 |
Tsung Ming Su
BRD | Director/Board Member | 69 | 05/07/2010 |
Chiu Ju Shih
BRD | Director/Board Member | - | 05/07/2010 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.37% | -1.37% | -5.25% | -15.92% | 544M | |
| -1.46% | +0.05% | +18.49% | +210.12% | 926B | |
| +0.61% | +1.48% | +57.70% | +54.70% | 586B | |
| -1.71% | +3.27% | +16.23% | +50.07% | 412B | |
| +0.03% | +5.18% | +25.48% | +32.27% | 382B | |
| +0.13% | +9.73% | +32.68% | +35.31% | 326B | |
| -0.78% | +5.27% | +33.05% | +58.65% | 317B | |
| +0.09% | +1.54% | +45.46% | +11.08% | 302B | |
| +0.45% | -1.16% | -45.33% | -36.86% | 218B | |
| +1.56% | +3.03% | +29.00% | +58.54% | 201B | |
| Average | -0.18% | +2.05% | +20.75% | +45.80% | 366.97B | |
| Weighted average by Cap. | -0.37% | +2.94% | +26.74% | +80.84% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 3.13B 99.53M 84.23M 76.84M 73.47M 136M 9.03B 141M 896M 355M 4.36B 373M 366M 15.36B | 3.29B 104M 88.42M 80.66M 77.13M 143M 9.48B 148M 940M 372M 4.57B 392M 384M 16.13B |
| Net income | 275M 8.73M 7.39M 6.74M 6.45M 11.94M 792M 12.36M 78.58M 31.13M 382M 32.75M 32.08M 1.35B | 339M 10.77M 9.11M 8.31M 7.95M 14.72M 976M 15.23M 96.87M 38.38M 471M 40.38M 39.54M 1.66B |
| Net Debt | - | - |
Employees
-
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/02/26 | 21.65 NT$ | -1.37% | 2,079,646 |
| 10/02/26 | 21.95 NT$ | -4.15% | 2,643,881 |
Sell
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
21.65TWD
Average target price
18.00TWD
Spread / Average Target
-16.86%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 1789 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition